Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saimirra Innopharm
Chennai, Tamil Nadu, Indiasaimirra.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Manufactures and supplies over 275 products across 70 countries under its international business. In India, its domestic formulations business operates under Delvin Formulations with over 20 brands across multiple therapies.
- Therapeutic areas
- Other
- Modalities
- Formulationstabletscapsulesliquidscreamsointmentspowders in sachetssoft gelatin capsules
- Industry
- Biotech
02
Partnerships
Piramal AlternativesBPEA Credit/Ascertis Credit
Beyond the preview
Go deeper on Saimirra Innopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Saimirra Innopharm.